Targeting Bacterial Biofilms by the Green Tea Polyphenol EGCG

Area of Science:

• Microbiology
• Biochemistry
• Plant Science

Background:

• Bacterial biofilms are resilient microbial communities implicated in chronic infections.
• Existing treatments often fail against biofilms due to their resistance to antibiotics and host defenses.
• Novel anti-biofilm strategies are urgently needed to combat persistent infections.

Purpose of the Study:

• To investigate the anti-biofilm properties of Epigallocatechin-3-gallate (EGCG).
• To elucidate the mechanisms by which EGCG affects biofilm matrix production.
• To assess the potential of EGCG as an anti-biofilm agent against various infection types.

Main Methods:

• Review of existing literature on EGCG and bacterial biofilms.
• Analysis of EGCG's interference with amyloid fiber assembly and cellulose production.
• Examination of EGCG's impact on cell envelope stress responses in bacteria.

Main Results:

• EGCG inhibits biofilm formation by interfering with amyloid fiber assembly and cellulose production.
• EGCG triggers a cell envelope stress response that down-regulates biofilm matrix synthesis.
• EGCG's efficacy varies depending on the biofilm matrix composition; it may be ineffective or even promote biofilms with different matrix types.
• EGCG shows potential against biofilms in cariogenesis and chronic wound infections, as well as against toxic amyloids in neuropathological diseases.

Conclusions:

• EGCG is a promising anti-biofilm compound with dual mechanisms of action.
• The effectiveness of EGCG is matrix-dependent, highlighting the need for targeted anti-biofilm strategies.
• EGCG's anti-amyloidogenic properties extend its potential therapeutic applications beyond bacterial infections to neurodegenerative diseases.